Scaling Digital Health Through Partnership: How DKV and Lifelight Collaborate on Prevention
Digital health is increasingly shaped by connected ecosystems that bring prevention and care closer together. This interview explores how corporate–startup collaboration helps turn innovative technologies into scalable healthcare solutions. At the centre is QC+ (Quiero Cuidarme Más), the digital health platform of DKV, combining self-care, prevention and clinical services in one seamless journey. A recent example is the integration of Lifelight, enabling smartphone-based blood pressure screening without additional hardware — demonstrating how digital innovation can support earlier detection and more accessible care. In this interview Judit Faus i Garriga, shares insights into the ecosystem behind QC+, the collaboration with Lifelight, and what it takes to scale digital health innovation successfully.
Judit, what is QC+ and the DKV digital ecosystem about?
QC+ (DKV Quiero cuidarme Más) is DKV’s digital front door for health. It brings prevention, self‑care, and access to clinical services into a single experience: users can manage their wellbeing and, when needed, seamlessly move into care through services such as medical chat, video consultations with primary care and specialists, and dedicated support services (e.g., coaching and midwife chat). Behind the scenes, this is supported by our clinical and care‑management systems, including uClinic and our electronic health record environment.
QC+ is part of DKV’s broader digital ecosystem, built to be modular and scalable. This ecosystem allows us to integrate carefully selected third‑party solutions in a safe and consistent way, while keeping the end‑to‑end journey coherent for the user. Examples include Mediktor (symptom checker), Lifelight (smartphone‑based blood pressure measurement), ReHub (telerrehabilitation), mental and emotional wellbeing questionnaires, and access to the memodio vida app (frailty prevention).
How did the new Lifelight feature come about?
The Lifelight feature emerged from a clear prevention priority: enabling scalable cardiovascular risk screening through a simple digital journey. Hypertension was selected as a starting point because it is common, often goes unnoticed, and early identification can support timely follow‑up and better long‑term outcomes. We wanted to reduce friction in early detection by allowing people to check their blood pressure without additional hardware, using only their smartphone.
Lifelight has been a strong partner because it combines innovation with clinical and regulatory robustness. It is positioned as a CE-marked Class IIa solution for camera‑based blood pressure measurement and has been tested in real‑world contexts such as pilots with the NHS in the UK. For DKV, it strengthens our prevention offering within QC+ and provides a structured opportunity to keep learning—together with Lifelight—about what it takes to drive adoption of digital health innovative solutions at scale.
Why is this feature important for people aged 40–74?
This age group is highly relevant because the risk of hypertension increases significantly with age, yet many people remain undiagnosed or inconsistently monitored. The condition is frequently ‘silent’, so proactive screening can be an effective way to surface risk earlier.
Early detection matters because it can prompt lifestyle changes and timely, clinician‑led follow‑up before complications develop. In QC+, we make screening easy to start and connect it to professional support through the medical chat. The GP follows a defined clinical protocol, ensuring next steps are safe, appropriate, and tailored to the user’s situation.
How did the collaboration with your partner Lifelight develop?
We developed the partnership in a structured way, treating regulation, clinical safety, and user experience as one integrated design challenge. Because this is a regulated solution, we aligned early on what could be adapted, how to frame results responsibly, and how to connect screening to clinician‑led follow‑up within QC+.
In parallel, we are building the operational backbone needed to scale: device‑compatibility management, reporting routines, and a shared KPI framework to track adoption, experience, and clinical impact—without oversimplifying success to a single metric. This also helps us move into an ongoing ‘optimization and learning’ phase where both DKV and Lifelight can continuously improve the service.
Have you received feedback on the new feature?
We’ve received early signals from internal users in the target age range and from initial operational monitoring—and that feedback is already shaping our next iterations. Early learning confirms the service is compelling, but it also shows we can improve the ‘conversion’ from measurement to the next clinical action—especially after an abnormal result, where we want more users to initiate the medical chat and complete the follow‑up steps.
A key improvement area is therefore to strengthen the step from measurement to clinician‑led follow‑up, making the value and the next step clearer and reducing any friction in the flow.
What are you looking forward right now?
In 2026, when it comes to Lifelight, we are excited to move from a successful rollout to delivering long-term measurable impact. That means refining the end‑to‑end journey, so more people complete the screening and, when results are out of range, take the right next step and connect with care.
More broadly, 2026 is about speeding up how DKV adopts and scales digital health innovation, strengthening our ecosystem so access to care feels increasingly seamless, and pushing further toward personalisation at scale.
We also want to double down on continuous, personalised prevention—through approaches such as PPG‑based screening, predictive risk models, and validated digital therapeutics, while keeping trust and clinical rigor at the centre. Our current process with Certificate DKV helps us do that by applying a structured assessment so we prioritise solutions that are safe, effective, and genuinely valuable for our clients.
Ultimately, what excites us most is making sure innovation translates into real, everyday value, helping people feel supported and make better health decisions, with technology enhancing human care.
Contact:
Website: dkv.es/corporativo/
LinkedIn: Judit Faus i Garriga